Beximco Pharmaceuticals Ltd. logo

Beximco Pharmaceuticals Ltd. (BXP)

Market Closed
12 Aug, 15:30
LSE LSE
56. 00
GBX
+1
+1.8182%
GBX
111.53M Market Cap
- P/E Ratio
12.7% Div Yield
1,187 Volume
- Eps
55 GBX
Previous Close
Add Transaction
Day Range
54.13 56
Year Range
0.43 57
Want to track BXP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BXP closed today higher at 56 GBX, an increase of 1.8182% from yesterday's close, completing a monthly increase of 12% or 6 GBX. Over the past 12 months, BXP stock gained 31.7647%.
BXP is not paying dividends to its shareholders.
The last earnings report, released on Jan 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Beximco Pharmaceuticals Ltd. has completed 7 stock splits, with the recent split occurring on Nov 23, 2020.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

BXP Chart

People also search for

The Property Franchise Group PLC
442.5 GBX
0%
VTU
Vertu Motors plc
84.3 GBX
-0.1185%
IGR
Baltic Bridge S.A.
95.5 GBX
-3.5354%
Keystone Law Group Plc
549 GBX
0%
CHH
Churchill China plc
385 GBX
-1.2821%

Beximco Pharmaceuticals Ltd. (BXP) FAQ

What is the stock price today?

The current price is 56.00 GBX.

On which exchange is it traded?

Beximco Pharmaceuticals Ltd. is listed on LSE.

What is its stock symbol?

The ticker symbol is BXP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 12.7%.

What is its market cap?

As of today, the market cap is 111.53M.

Has Beximco Pharmaceuticals Ltd. ever had a stock split?

Beximco Pharmaceuticals Ltd. had 7 splits and the recent split was on Nov 23, 2020.

Beximco Pharmaceuticals Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
LSE Exchange
US0885792061 ISIN
Bangladesh Country
5,500 Employees
22 Nov 2024 Last Dividend
23 Nov 2020 Last Split
- IPO Date

Overview

Beximco Pharmaceuticals Limited, established in 1976 and headquartered in Dhaka, Bangladesh, stands as a notable entity in the pharmaceutical industry. The company specializes in manufacturing and marketing a broad spectrum of generic pharmaceutical formulations and active pharmaceutical ingredients. Catering to both the local market in Bangladesh and international clientele, Beximco Pharmaceuticals Limited ensures a significant presence in the global pharmaceutical landscape. Furthermore, the company extends its proficiency by offering contract manufacturing services, thereby supporting other companies within the pharmaceutical sector.

Products and Services

The range of products and services offered by Beximco Pharmaceuticals Limited caters to a diverse array of medical needs and pharmaceutical requirements:

  • Allergic Disorder Medications: Products designed to manage and treat various allergic reactions.
  • Analgesics and Antipyretics: Offering pain relief and fever reduction medications.
  • Anti-infective Agents: A comprehensive range targetting bacterial, viral, and other infections.
  • Antiviral Treatments: Medications specifically aimed at combating viral infections.
  • Cardiovascular Medications: Products focused on heart health and managing cardiovascular diseases.
  • Central Nervous System (CNS) Drugs: Medications for treating neurological disorders and conditions affecting the CNS.
  • Cough and Cold Remedies: A variety of treatments for symptomatic relief of cough and cold.
  • Endocrine and Diabetes Care: Medications for managing diabetes and other endocrine disorders.
  • Eye Care Products: A lineup dedicated to treating various eye-related conditions.
  • Gastrointestinal Medications: Drugs aimed at addressing issues within the gastrointestinal tract.
  • Hormone and Steroid Therapies: Treatments revolving around hormone replacement and steroid use.
  • Intravenous Fluids: Essential for hydration and electrolyte balance in medical settings.
  • Musculoskeletal Drugs: Medications focused on bone health and treating conditions affecting muscles and bones.
  • Oncology Treatments: A specialized range dedicated to cancer care and management.
  • Respiratory Medications: Drugs designed to treat various respiratory conditions.
  • Urogenital Care: Medications for treating diseases of the urinary system and genitals.
  • Skin Care Products: Treatments and care products for a variety of skin conditions.
  • Vitamin and Mineral Supplements: A broad spectrum of supplements to support overall health and well-being.

Each product category is formulated in various dosage forms including sold, liquid, cream and ointment, suppositories, metered dose and dry powder inhalers, nasal sprays, sterile, lyophilized injectables, and large volume intravenous fluids, showcasing Beximco Pharmaceuticals Limited’s versatile manufacturing capabilities.

Contact Information

Address: 19 Dhanmondi R/A
Phone: 880 2 5861 1001